| __timestamp | Arrowhead Pharmaceuticals, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 4733600000 |
| Thursday, January 1, 2015 | 57410147 | 4796400000 |
| Friday, January 1, 2016 | 41454452 | 5243900000 |
| Sunday, January 1, 2017 | 31690298 | 5281800000 |
| Monday, January 1, 2018 | 52968505 | 5051200000 |
| Tuesday, January 1, 2019 | 81048686 | 5595000000 |
| Wednesday, January 1, 2020 | 128874979 | 6085700000 |
| Friday, January 1, 2021 | 206342000 | 7025900000 |
| Saturday, January 1, 2022 | 297307000 | 7190800000 |
| Sunday, January 1, 2023 | 353188000 | 9313400000 |
| Monday, January 1, 2024 | 505870000 | 14271000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, Eli Lilly and Company has consistently outpaced Arrowhead Pharmaceuticals, Inc. in R&D spending. From 2014 to 2023, Eli Lilly's R&D expenses grew by approximately 97%, peaking at $9.3 billion in 2023. In contrast, Arrowhead Pharmaceuticals, while showing a significant upward trend, increased its R&D investment by over 2,000%, reaching $353 million in 2023.
This stark difference highlights the scale and resources of a pharmaceutical giant like Eli Lilly compared to a smaller, yet rapidly growing, biotech firm like Arrowhead. The data underscores the importance of R&D in maintaining competitive advantage and driving future breakthroughs in medicine. As we look to the future, these investments will likely shape the landscape of healthcare innovation.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.